$PRVB
Provention Bio Inc
PRICE
$3.43 ▼-14.25%
Last Close
VOLUME
594,281
DAY RANGE
3.39 - 4.045
52 WEEK
3.39 - 8.04
Join Discuss about PRVB with like-minded investors
Key Metrics
Market Cap
219.66 M
Beta
1.62
Avg. Volume
671.29 K
Shares Outstanding
64.04 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed by the U.S. Food and Drug Administration (FDA). The Company's pipeline includes additional clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in other autoimmune diseases, including celiac disease and lupus.
CEO: Ashleigh Palmer
Website: www.proventionbio.com
HQ: 55 Broad Street, 2Nd Floor Red Bank, 07701 New Jersey
Related News